Skip to main content
Clinical Trials/ISRCTN97009661
ISRCTN97009661Completed未知

Evaluating the feasibility, suitability and potential efficiency of Cannabis Sativa oil on pain and quality of life assessment for patients with burning mouth syndrome: a prospective open-label single-arm pilot study

niversity of Turin0 sites17 target enrollmentStarted: May 6, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
17

Study Overview

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/33123730/ (added 02/12/2020)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Aged = 18
  • 2. Burning mouth syndrome diagnosis
  • 3. No detectable oral mucosal lesions
  • 4. Able to complete the present clinical trial

Exclusion Criteria

  • 1. Unable or unwilling to provide informed consent
  • 2. Significant psychiatric or cognitive impairment
  • 3. Other diagnoses that could explain the neuropathic pain
  • 4. Diagnosis of Sjögren Syndrome on the basis of AECG criteria
  • 5. Previous head and neck radiotherapy
  • 6. Diagnosed lymphoma
  • 7. Hepatitis C infection
  • 8. Pregnant or breast-feeding women

Investigators

Sponsor
niversity of Turin

Similar Trials